Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007418
Filing Date
2025-05-12
Accepted
2025-05-12 16:59:11
Documents
85
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20250331x10q.htm   iXBRL 10-Q 2165576
2 EX-31.1 chrs-20250331xex31d1.htm EX-31.1 13969
3 EX-31.2 chrs-20250331xex31d2.htm EX-31.2 14862
4 EX-32.1 chrs-20250331xex32d1.htm EX-32.1 11963
  Complete submission text file 0001558370-25-007418.txt   9290389

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20250331.xsd EX-101.SCH 66803
6 EX-101.CAL chrs-20250331_cal.xml EX-101.CAL 82033
7 EX-101.DEF chrs-20250331_def.xml EX-101.DEF 314692
8 EX-101.LAB chrs-20250331_lab.xml EX-101.LAB 531521
9 EX-101.PRE chrs-20250331_pre.xml EX-101.PRE 460733
88 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250331x10q_htm.xml XML 1564834
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 25935790
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)